sr9009 and Immune-System-Diseases

sr9009 has been researched along with Immune-System-Diseases* in 1 studies

Reviews

1 review(s) available for sr9009 and Immune-System-Diseases

ArticleYear
The transcriptional repressor REV-ERB as a novel target for disease.
    Bioorganic & medicinal chemistry letters, 2020, 09-01, Volume: 30, Issue:17

    REV-ERB is a member of the nuclear receptor superfamily of transcription factors involved in the regulation of many physiological processes, from circadian rhythm, to immune function and metabolism. Accordingly, REV-ERB has been considered as a promising, but difficult drug target for the treatment of numerous diseases. Here, we concisely review current understanding of the function of REV-ERB, modulation by endogenous factors and synthetic ligands, and the involvement of REV-ERB in select human diseases. Particular focus is placed on the medicinal chemistry of synthetic REV-ERB ligands, which demonstrates the need for higher quality ligands to aid in robust validation of this exciting target.

    Topics: Animals; Circadian Rhythm; Heme; Humans; Immune System Diseases; Ligands; Nuclear Receptor Subfamily 1, Group D, Member 1; Receptors, Cytoplasmic and Nuclear; Repressor Proteins; Structure-Activity Relationship

2020